University of Alberta-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Alberta - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013596
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Alberta (UALBERTA) is an educational university that provides undergraduate, international, graduate, continuing studies and open studies programs. The university offers educational programs in agricultural food and nutritional science, English and film studies, history and classics, forest science and management, human ecology, art and design, drama, resource economics and environmental sociology, chemicals and material engineering, economics, interdisciplinary studies, psychology, sociology, women’s studies, modern languages and cultural studies, music, and others. It offers translational and discovery driven research across various areas of impact in science, social sciences, humanities and fine arts. UALBERTA is headquartered in Edmonton, Alberta, Canada.

University of Alberta – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Alberta, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Alberta, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Alberta, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Alberta, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Alberta, Medical Devices Deals, 2011 to YTD 2017 9
University of Alberta, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Alberta, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Corline Biomedical to Enter into Agreement with University of Alberta 11
Licensing Agreements 12
Ceapro Expands Licensing Agreement with University of Alberta 12
Ceapro Enters into Licensing Agreement with University of Alberta 13
Asset Transactions 14
NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 14
ProtoKinetix Acquires Certain Patents from University of Alberta 15
University of Alberta – Key Competitors 16
University of Alberta – Key Employees 17
University of Alberta – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 19
Recent Developments 20
Government and Public Interest 20
Oct 11, 2017: Uncovering origins of developmental brain disorders could eventually help treat seizures 20
Sep 01, 2017: New technology could reduce costs significantly in protein analysis during drug development 21
Mar 23, 2017: Possible new target for treatment of multiple sclerosis found by U of A researchers 22
Nov 29, 2016: Drugs prevent heart damage during breast cancer treatment, study show 23
Jul 04, 2016: HPV vaccine reduced cervical abnormalities in young women 25
Other Significant Developments 26
Oct 17, 2017: Scientific Update for Diabetes, Kidney Ischemia, Liver Perfusion, Retinal Cell Replacement, Monoclonal Antibody Production and Immune Cell Cryopreservation Recovery 26
Jul 21, 2017: IBM and University of Alberta Publish New Data on Machine Learning Algorithms to Help Predict Schizophrenia 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
University of Alberta, Pharmaceuticals & Healthcare, Key Facts 2
University of Alberta, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Alberta, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Alberta, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Alberta, Deals By Therapy Area, 2011 to YTD 2017 8
University of Alberta, Medical Devices Deals, 2011 to YTD 2017 9
University of Alberta, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Corline Biomedical to Enter into Agreement with University of Alberta 11
Ceapro Expands Licensing Agreement with University of Alberta 12
Ceapro Enters into Licensing Agreement with University of Alberta 13
NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 14
ProtoKinetix Acquires Certain Patents from University of Alberta 15
University of Alberta, Key Competitors 16
University of Alberta, Key Employees 17
University of Alberta, Other Locations 18
University of Alberta, Subsidiaries 18
University of Alberta, Joint Venture 19

★海外企業調査レポート[University of Alberta-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lansdowne Oil & Gas plc (LOGP):石油・ガス:M&Aディール及び事業提携情報
    Summary Lansdowne Oil & Gas Plc (Lansdowne Oil & Gas) is an independent oil and gas exploration and production company. The company acquires, explores and develops crude oil and natural gas appraisals in the North Celtic Sea Basin offshore in southern Ireland. It develops Barryroe Field in the North …
  • Ansvar Insurance Limited:企業の戦略・SWOT・財務分析
    Ansvar Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary Ansvar Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Merafe Resources Ltd:企業の戦略・SWOT・財務分析
    Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Merafe Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Development Bank of Japan Inc:企業の戦略・SWOT・財務情報
    Development Bank of Japan Inc - Strategy, SWOT and Corporate Finance Report Summary Development Bank of Japan Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Lagerwey Wind BV-エネルギー分野:企業M&A・提携分析
    Summary Lagerwey Wind BV (Lagerwey) is an alternative energy company that design and manufacture of wind turbines. The company’s wind turbines include L82-2.0 MW, L93 1.5 MW, L93 2.6 MW, L100 1.5 MW, L100 2.5 MW, L100- NL and L132-3.8 MW. Its technologies comprise turbine modular set-up, Nacelle, ge …
  • Juniper Pharmaceuticals Inc (JNP):製薬・医療:M&Aディール及び事業提携情報
    Summary Juniper Pharmaceuticals Inc (Juniper), formerly Columbia Laboratories Inc is a women’s health therapeutic company that focuses on developing therapeutics that address unmet medical needs. It develops, manufactures, licenses and sells pharmaceutical products in women's health. The company uti …
  • Cheetah Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Cheetah Medical Inc (Cheetah Medical) is a provider of non-invasive hemodynamic monitoring technologies. The company’s products comprise CHEETAH NICOM prewired sensors and Starling SV systems. It also offers Starling SV system accessories such as monitors and sensors, replacement parts, pole …
  • Sunstone Hotel Investors Inc:戦略・SWOT・企業財務分析
    Sunstone Hotel Investors Inc - Strategy, SWOT and Corporate Finance Report Summary Sunstone Hotel Investors Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Abiomed Inc (ABMD):医療機器:M&Aディール及び事業提携情報
    Summary Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It develops, manufactures and markets novel technologies designed to replace or assist the pumping function in a failing heart. The company’s heart support and recovery product portfolio includes catheters for cir …
  • SunTech Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary SunTech Medical Inc (SunTech) is a medical device company that manufactures and markets clinical-grade non-invasive blood pressure monitoring products and technologies. The company provides products such as ambulatory blood pressure monitoring products, blood pressure w and vitals, blood pre …
  • SEGRO Plc:企業のM&A・事業提携・投資動向
    SEGRO Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SEGRO Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • San Miguel Brewery Hong Kong Ltd.
    San Miguel Brewery Hong Kong Ltd. - Strategy, SWOT and Corporate Finance Report Summary San Miguel Brewery Hong Kong Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Orexo AB (ORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Orexo AB (Orexo) is a specialty pharmaceutical company that focuses on the research, formulation, development, registration and commercialization of drugs. The company's commercial product portfolio consists of Abstral, Edluar and Zubsolv. its pipeline candidates comprise OX51 for procedure- …
  • Ceres Power Holdings plc (CWR):企業の財務・戦略的SWOT分析
    Summary Ceres Power Holdings Plc (Ceres Power) operates as an alternative energy company that develops low cost and next generation fuel cell technologies. The company carries out developing steel cell a fuel cell technology that converts natural gas and hydrogen fuel directly into electrical power …
  • Oxford Performance Materials Inc-医療機器分野:企業M&A・提携分析
    Summary Oxford Performance Materials Inc (OPMI), a subsidiary of Arkema Inc is a chemical company that manufactures thermoplastic polymers. The company’s products include proprietary polyether ketone ketone formulations, additives, complex assemblies, biomedical raw materials, biomedical parts, robo …
  • Clean Harbors, Inc. (CLH)-石油・ガス分野:企業M&A・提携分析
    Summary Clean Harbors, Inc. (Clean Harbors) is a provider of environmental, industrial and energy services. The company offers waste disposal and recycling, emergency response, chemical packing, field services, production services, exploration services, directional boring, lodging services and insit …
  • Aprecia Pharmaceuticals Company:製薬・医療:M&Aディール及び事業提携情報
    Summary Aprecia Pharmaceuticals Company (Aprecia) is a drug delivery technology platform company that develops pharmaceutical drug products. The company offers Zipdose technology, a delivery platform that serves as the foundation of orodispersible formulations of prescribed high-dose medications. It …
  • SPX Flow Inc (FLOW):企業の財務・戦略的SWOT分析
    SPX Flow Inc (FLOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Midea Group Co Ltd:企業の戦略・SWOT・財務分析
    Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Midea Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • NanoBio Corp-製薬・医療分野:企業M&A・提携分析
    Summary NanoBio Corp (NanoBio) is a biopharmaceutical company that develops vaccines. The company develops and commercializes intranasal and intramuscular vaccines for the prevention and treatment of infectious diseases. The company's vaccines include anthrax, H5 influenza, pertussis, RSV, HIV, HSV- …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆